Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (2): 214-217    DOI: 10.12891/ceog3820.2018
Original Research Previous articles | Next articles
Depression, anxiety, and stress after preterm delivery: role of previous progesterone therapy
E. Djakovic1, *(), S. Rakic1
1 Gynaecology and Obstetrics Clinic “Narodni front”, Belgrade, Serbia
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose of the study: To determine the influence of progesterone therapy in imminent preterm delivery on early postpartum anxiety, stress, and depression symptoms and to compare the scores of two scales: the Depression, Anxiety and Stress Scale (DASS) and the Edinburgh Postpartum Depression Scale (EPDS) on third day postpartum. Materials and Methods: The sample consisted of 37 women on progesterone therapy between 28 and 37 weeks who delivered prematurely. Controls were 40 pregnant women without progesterone therapy who also delivered prematurely. On third postpartum day all participants completed DASS and EPDS. Student's t-test (Leven correction for small samples) compared the scores of these two scales. Results: The control group showed significantly higher levels of depression symptoms in DASS questionnaire on third day after preterm delivery. Conclusions: Progesterone lowers the intensity of depressive symptoms after preterm delivery. The DASS scoring system was effective in early detection of postpartum depressive symptoms.
Key words:  Progesterone therapy      Preterm delivery      Postpartum depression     
Published:  10 April 2018     
*Corresponding Author(s):  E. DJAKOVIC     E-mail:  djakovicelena7@gmail.com

Cite this article: 

E. Djakovic, S. Rakic. Depression, anxiety, and stress after preterm delivery: role of previous progesterone therapy. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 214-217.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3820.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I2/214

[1] N. Dropińska, K. Chmaj-Wierzchowska, M. Wojciechowska, M. Wilczak. What is the state of knowledge on preterm birth?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 505-510.
[2] C. Chollet, B. Andre, M. Voglimacci, A. Ghassani, O. Parant, P. Guerby. Perinatal outcomes of second trimester antenatal genital bleeding[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 105-110.
[3] R. Csorba, P. Tsikouras, A. Bothou, S. Zervoudis, G. Iatrakis, X. Anthoulaki, D. Deuteraiou, A. Chalkidou, G. F. von Tempelhoff. Air travel during pregnancy: an update review and practical recommendation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 862-866.
[4] A. Średniawa, K. Kruk, D. Ł. Jarczewska, K. Żabicka, M. Golonka, R. Krępa, T. Tomasik. Postpartum depression and breastfeeding in primary care in Krakow, Poland[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 880-885.
[5] H. Alchalabi, Y.S. Khader, I. Lataifeh, B. Obeidat, F. Zayed, W. Khriesat, N. Obeidat. Morbidly adherent placenta previa: clinical course and risk from emergency delivery in a series of 26 women that underwent hysterectomy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 524-527.
[6] J.L. Reed, E.E. Winger. IVIg therapy increases delivery birthweight in babies born to women with elevated preconception proportion of peripheral blood (CD56+/CD3-) natural killer cells[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 384-391.
[7] K.P. Fuller, S. DeGroff, A.F. Borgida. Neonatal outcomes based on antenatal corticosteroid exposure time for infants delivered between 23 and 34 weeks gestation[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 247-251.
[8] S. Nergiz Avcioğlu, S.Ö. Altinkaya, S. Demi̇rcan Sezer, İ.K. Ömürlü, M. Küçük, H. Yüksel. Predictive value of procalcitonin and IL-6 versus cervical length for the admission-to-delivery interval in preterm labour[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 39-43.
[9] M. Hadži-Lega, A. Daneva Markova, M. Stefanovic, M. Tanturovski. Combination of selected biochemical markers and cervical length in the prediction of impending preterm delivery in symptomatic patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(1): 154-160.
[10] M. Öz, B. Polat, E. Özgü, K. D. Seçkin, C. Taşin, N. Danişman. Interleukin-6 and C-reactive protein levels in the amniotic fluid as indicators of preterm delivery in Turkish women[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(6): 801-804.
[11] G. Batmaz, B. Dane, A. Sarioglu, Z. Kayaoglu, C. Dane. Can we predict postpartum depression in pregnant women?[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(5): 605-609.
[12] J.H. Check. A practical approach to diagnosing and treating infertility by the generalist in obstetrics and gynecology[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(4): 405-410.
[13] G. Carta, A. D’Alfonso, V. Parisse, A. Di Fonso, M. Casacchia, F. Patacchiola. How does early cognitive behavioural therapy reduce postpartum depression?[J]. Clinical and Experimental Obstetrics & Gynecology, 2015, 42(1): 49-52.
[14] J. Sun, S. Qu, C. Zhang, Z. Xiang, Z. Fu1, L. Yao. Neonatal mortality rate and risk factors in northeast China: analysis of 5,277 neonates in 2005[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 512-516.
[15] T.S. Patrelli, S. Gizzo, M. Plebani, D. Basso, G. Capobianco, C. Bartolucci, A. Bacchi Modena, M. Rondinelli, G.B. Nardelli. The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(1): 57-64.
No Suggested Reading articles found!